IP Library Granted Patent US 11,065,271
Granted Patent B2
US 11,065,271 · App. 16/681,398 · Granted Jul 20, 2021

Maternal vitamin B12 administration for the prevention of increased adiposity, overweight or obesity in the offspring especially offspring overweight and/or obese mothers

Inventors: Cyrus Cooper (Southampton Hampshire, GB); Peter David Gluckman (Auckland, NZ); Irma Silva Zolezzi (Carrouge, CH); Keith Malcolm Godfrey (Ashurst Hampshire, GB); Catherine Mace (Lausanne, CH)
Assignee: Societe des Produits Nestle S.A.
A61K31/714A23L33/15A23L33/30A23L33/40A61K9/0095A61K45/06A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,065,271
App. No.
16/681,398
Granted
Jul 20, 2021
Kind
B2
Abstract

The present invention generally relates to the early prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in infants or children. For example, the present invention relates to the prevention of over-weight, obesity, excessive fat accumulation and/or associated metabolic disorders in infants or children through appropriate nutrition for women desiring to get pregnant and/or during pregnancy and/or lactation. Embodiments of the present invention relate to vitamin B12 for use in the prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in the off-spring, wherein the vitamin B12 is administered to an overweight and/or obese women desiring to get pregnant and/or to the over-weight and/or obese mother during pregnancy and/or lactation and to maternal food compositions that can be used for this purpose.

Claims (5)

1. A maternal food composition comprising a protein source, a carbohydrate source, a lipid source, lecithin, bulking agents, probiotic bacteria, and 0.18-18.2 μg vitamin B12/100 g dry weight of the maternal food composition.

2. The maternal food composition of claim 1 , further comprising at least one component selected from the group consisting of folic acid, calcium, iron, arachidonic acid (ARA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

3. The maternal food composition of claim 1 , wherein the maternal food composition is selected from the group consisting of a powdered nutritional composition to be reconstituted in milk or water, a nutritional formula, a cereal-based product, a drink, a bar, a nutritional supplement, a nutraceutical, a yogurt, a dairy based product, a food sprinkler, a pill and a tablet.

4. The maternal food composition of claim 1 , comprising a natural source that provides at least a portion of the vitamin B12.

5. The maternal food composition of claim 1 , formulated for administration to an overweight and/or obese mother before pregnancy, during pregnancy and/or during lactation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2021
From: COOPER, CYRUS; GLUCKMAN, PETER DAVID; GODFREY, KEITH MALCOLM; MACE, CATHERINE; SILVA ZOLEZZI, IRMA
To: NESTEC S.A.
Reel/Frame 056582/0943 →
MERGER Recorded Jun 18, 2021
From: NESTEC S.A.
To: SOCIETE DES PRODUITS NESTLE S.A.
Reel/Frame 056582/0981 →
Priority Claims (2)
EP 14150793 · Jan 10, 2014 · regional
EP 14161184 · Mar 21, 2014 · regional
Continuity (2)
Division 15107570
Related Publication 20200188421A1 · Jun 18, 2020